Our History - Verséa
 

2017

May 2017

Verséa Conceptualized

  • Founders enter & conduct due diligence within the pharmaceutical Alt-Therapies market

October 2017

Thought Leaders Developed

  • Initial introduction for the company mission with Key Opinion Leaders (KOLs) and pharmaceutical executives in the pain and CNS specialties
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2018

July 2018

Verséa Founded

  • Verséa Holdings, Inc. was formed after founders exited a public sale in the medical space 

July 2018

Off We Go!

  • Core executive leadership team expands to 6 and founders capital vested.

September 2018

Verséa Wellness division created

  • Verséa Wellness brand launch at medical conference

October 2018

Medical Team Expands!

  • Medical Director and Physician Advisors Sign On

December 2018

Brand Launch

  • Soft launch of company & products at medical conferences 
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2019

February 2019

Clinical Research Begins

  • Completes 2 IRB studies accepted for medical publication

April 2019

Nationalwide sale of Verséa Clinical Wellness products

  • Verséa Wellness products hit the direct to clinician market nationwide

May 2019

Team Expansion

  • Clinical and regulatory experts join
  • Core management team expands to 9
  • Medical advisory team to 14

September 2019

Verséa Diagnostics division formed

  • Verséa Diagnostics division formed

October 2019

Diagnostics Products (POC & OTC) Offered in 30+ States

  • Verséa Diagnostics POC & OTC products available nationwide

December 2019

Custom CRM and Sales System Buildout Complete

  • Verséa releases its own customized software solution to help manage: products, sales, distribution for master distributors, hcps and consumers with ordering and fulfillment.
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2020

March 2020

Vertical Expansion

  • 4+ NIH grant submissions
  • Operations expansion globally into EAU and FDA Diagnostics
  • Versea aligns with expanded customer base to include urgent care groups, major hospitals and surgery centers (ASC’s) nationally

June 2020

Portfolio Expansion

  • 25+ medical doctors sign MSA and take on clinical and commercial advisory roles
  • GPO’s, Ex US expansion, Telehealth & large partnerships executed for scalability

September 2020

First in USA!

  • Verséa and its research partner, VitaMed Research, achieves 1st in the United States HIPPA Compliant IRB Approved, Patient Registry.
  • Research study quickly enrolls 300+  Patients completing INH survey month to month on Verséa  products

December 2020

Verséa partners with leading Diagnostics manufacturers

  • Verséa secures partnerships with leading manufacturers of point of care diagnostics
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2021

March 2021

New Formulation

  • Versea launches a new Wellness portfolio using patented technology that allows superior delivery of botanicals with 4.4x better absorption than standard formulations currently on the market

June 2021

Team Expansion + New Division

  • Team Expansion: Management and Medical Advisory teams expand

  •  New Business Divisions: Biologics, Discovery

September 2021

Patent Filing

  • Provisional Patent filed for our proprietary VCX™ Discovery Platform

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]